Investors

Event Calendar

 

Upcoming Events

Year End 2019 Financial Results week of 02 March 2020

March 2, 2020

Read more


ObsEva Annual General Meeting 2020: Thursday May 7, 2020

May 7, 2020

Read more


Half Year 2020 Financial Results week of 03 August 2020

August 3, 2020

Read more


1 2

Past Events

ObsEva to participate in The Credit Suisse Healthcare Conference, November 11-13, 2019

November 13, 2019

Read more

Third Quarter 2019 Financial Results 7 November 2019

November 7, 2019

Read more

ObsEva SA to Present Model-Based Analysis Supporting Clinical Use of Linzagolix at Doses Not Requiring Hormonal Add back Therapy

October 17, 2019

Read more
1 2 3 4 19

General Meetings

ObsEva Annual General Meeting 2020

May 7, 2020

Read more

ObsEva Annual General Meeting 2019

May 8, 2019

Read more
1 2 3
 
 

Sign up for news

 
 

* Type:


InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther












Read our privacy policy here.

 

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue